Bipolar and Related Disorders Induced by Sodium 4-Phenylbutyrate in a Male Adolescent with Bile Salt Export Pump Deficiency Disease.
- Author:
Giovanni VITALE
1
;
Giulia SIMONETTI
;
Martina PIRILLO
;
Gianfranco TARUSCHIO
;
Pietro ANDREONE
Author Information
- Publication Type:Case Report
- Keywords: Bipolar and related disorders; Sodium 4-phenylbutyrate; Progressive Familial Intrahepatic Cholestasis type 2
- MeSH: Adolescent*; Bile*; Bipolar and Related Disorders*; Body Weight; Carcinoma, Hepatocellular; Child; Cholestasis, Intrahepatic; Deficiency Diseases*; Humans; Hypertension, Portal; Infant; Liver; Liver Failure; Liver Transplantation; Male*; Rare Diseases; Sodium*
- From:Psychiatry Investigation 2016;13(5):580-582
- CountryRepublic of Korea
- Language:English
- Abstract: Bile Salt Export Pump (BSEP) Deficiency disease, including Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2), is a rare disease, usually leading within the first ten years to portal hypertension, liver failure, hepatocellular carcinoma. Often liver transplantation is needed. Sodium 4-phenylbutyrate (4-PB) seems to be a potential therapeutic compound for PFIC2. Psychiatric side effects in the adolescent population are little known and little studied since the drug used to treat children and infants. So we described a case of Caucasian boy, suffering from a late onset PFIC2, listed for a liver transplant when he was sixteen and treated with 4-FB (200 mg per kilogram of body weight per day). The drug was discontinued for the onset of bipolar and related disorders. This case illustrates possible psychiatric side effects of the drug.
